Post Covid-19 Mandibular Mucormycosis: A Rare and Deviant Site of Presentation

Article Sidebar

pdf
Published: Jul 29, 2023
DOI: https://doi.org/10.47210/bjohns.2022.v30i3.814
Keywords:
Covid-19 mucormycosis, Mandibular mucormycosis, Mucormycosis

Main Article Content

Ravishankar C
Bangalore Medical College and Research Institute, Bangalore, Karnataka, India
Hemalatha B R
Shri Atal Bihari Vajpayee Medical College & Research Institute, Bangalore, Karnataka, India
Pruthvi Raj S
Shri Atal Bihari Vajpayee Medical College & Research Institute, Bangalore, Karnataka, India
Architha Menon P
Shri Atal Bihari Vajpayee Medical College and Research Institute, Bangalore, Karnataka, India
Garima Singh
Bangalore medical college and research institute, Bangalore, Karnataka, India

Abstract

Introduction:Mandibular involvement in mucormycosis is rare, and only a few cases of post covid-19 mandibular mucormycosis have been reported to date.
Materials & methods: This is a retrospective descriptive case series study conducted at a tertiary care centre.We report the clinico-epidemiological profile and management of 5 cases of post covid mandibular mucormycosis. All patients received intravenous antifungals at the earliest and underwent surgical debridement of the infected bone.
Results: 4 patients were managed satisfactorily. 1 patient succumbed to the disease. Extent of debridement was based on the clinical, radiological and intraoperative assessment of the mandible.
Conclusion: Mandibular mucormycosis is rare and early recognition of symptoms and treatment is imperative in reducing the spread of disease, decreasing the extent of resection and postoperative reconstruction.

Article Details

How to Cite
1.
C R, B R H, Raj S P, Menon P A, Singh G. Post Covid-19 Mandibular Mucormycosis: A Rare and Deviant Site of Presentation. BJOHNS [Internet]. 2023Jul.29 [cited 2024May3];30(3):332-6. Available from: https://bjohns.in/journal3/index.php/bjohns/article/view/814
Issue
Vol. 30 No. 3 (2022): Bengal Journal of Otolaryngology and Head Neck Surgery
Section
Case series
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Author Biographies

Ravishankar C, Bangalore Medical College and Research Institute, Bangalore, Karnataka, India

Professor, Department of Otorhinolaryngology

Hemalatha B R, Shri Atal Bihari Vajpayee Medical College & Research Institute, Bangalore, Karnataka, India

Chief Dental Health Officer, Department of oral and maxillofacial surgery

Pruthvi Raj S, Shri Atal Bihari Vajpayee Medical College & Research Institute, Bangalore, Karnataka, India

Assistant Professor, Department of Otorhinolaryngology

Architha Menon P, Shri Atal Bihari Vajpayee Medical College and Research Institute, Bangalore, Karnataka, India

Assistant Professor, Department of Otorhinolaryngology

Garima Singh, Bangalore medical college and research institute, Bangalore, Karnataka, India

Postgraduate, Department of Otorhinolaryngology

References

Eisenberg L, Wood T, Boles R. Mucormycosis. Laryngoscope. 1977 Mar;87(3):347-56. doi: 10.1288/00005537-197703000-00007. PMID: 839930

Moorthy A, Gaikwad R, Krishna S, Hegde R, Tripathi KK, Kale PG, Rao PS, Haldipur D, Bonanthaya K. SARS-CoV-2, Uncontrolled Diabetes and Corticosteroids-An Unholy Trinity in Invasive Fungal Infections of the Maxillofacial Region? A Retrospective, Multi-centric Analysis. J Maxillofac Oral Surg. 2021 Sep;20(3):418-425. doi: 10.1007/s12663-021-01532-1. Epub 2021 Mar 6. PMID: 33716414; PMCID: PMC7936599

Sharma NC. India reports 40,854 cases of black fungus so far [Internet]. mint. 2021 [cited

Dec3]. Available from: https://www.livemint.com/news/india-records-over-40k-cases-

of-mucormycosis-11624875874985.html

Banerjee M, Pal R, Bhadada SK. Intercepting the deadly trinity of mucormycosis, diabetes and COVID-19 in India. Postgrad Med J. 2021 Jun 8:postgradmedj-2021-140537. doi: 10.1136/postgradmedj-2021-140537. Epub ahead of print. PMID: 34103372

Patel A, Agarwal R, Rudramurthy SM, Shevkani M, Xess I, Sharma R, et al. Multicenter Epidemiologic Study of Coronavirus Disease–Associated Mucormycosis, India. Emerg Infect Dis. 2021;27(9):2349-2359. https://doi.org/10.3201/eid2709.210934

Dasukil, S., Boyina, K.K., Sarkar, S. et al. Management of Covid Associated Mucormycosis of Mandible: A Mountain Beneath a Molehill—A Lesson Learnt. Indian J Otolaryngol Head Neck Surg 74 (Suppl 2), 3481–3484 (2022). https://doi.org/10.1007/s12070-021-02925-x

Ambereen A, Rahman SA, Rehman S, Zaidi K, Arif SH. Mandibular mucormycosis following SARS-CoV-2 infection - A case report and review of literature. Clin Infect Pract. 2021 Nov;12:100099. doi: 10.1016/j.clinpr.2021.100099. Epub 2021 Sep 20. PMID: 34568807; PMCID: PMC8450209.